Suchergebnis | Hamburg Open Science

Facetten

26 Einträge gefunden

Loss of CHD1 causes DNA repair defects and enhances prostate cancer therapeutic responsiveness
2016 - Forschungsinformationssystem des UKE
Prevalence of chromosomal rearrangements involving non-ETS genes in prostate cancer
2015 - Forschungsinformationssystem des UKE
High nuclear karyopherin α 2 expression is a strong and independent predictor of biochemical recurrence in prostate cancer patients treated by radical prostatectomy
2014 - Forschungsinformationssystem des UKE
High RNA-binding motif protein 3 expression is an independent prognostic marker in operated prostate cancer and tightly linked to ERG activation and PTEN deletions
2014 - Forschungsinformationssystem des UKE
Matrix Conditions and KLF2-Dependent Induction of Heme Oxygenase-1 Modulate Inhibition of HCV Replication by Fluvastatin
2014 - Forschungsinformationssystem des UKE - frei zugänglich
High c-MET expression is frequent but not associated with early PSA recurrence in prostate cancer.
2013 - Forschungsinformationssystem des UKE
SPINK1 expression is tightly linked to 6q15- and 5q21-deleted ERG-fusion negative prostate cancers but unrelated to PSA recurrence
2013 - Forschungsinformationssystem des UKE
Genomic deletion of MAP3K7 at 6q12-22 is associated with early PSA recurrence in prostate cancer and absence of TMPRSS2:ERG fusions
2013 - Forschungsinformationssystem des UKE
Intratumoral heterogeneity of KRAS mutation is rare in non-small-cell lung cancer.
2013 - Forschungsinformationssystem des UKE
Strong expression of the neuronal transcription factor FOXP2 is linked to an increased risk of early PSA recurrence in ERG fusion-negative cancers.
2013 - Forschungsinformationssystem des UKE
Loss of pSer2448-mTOR expression is linked to adverse prognosis and tumor progression in ERG-fusion-positive cancers.
2013 - Forschungsinformationssystem des UKE
High lysophosphatidylcholine acyltransferase 1 expression independently predicts high risk for biochemical recurrence in prostate cancers
2013 - Forschungsinformationssystem des UKE - frei zugänglich
Overexpression of the chromatin remodeler death-domain-associated protein in prostate cancer is an independent predictor of early prostate-specific antigen recurrence
2013 - Forschungsinformationssystem des UKE
Loss of CDKN1B/p27Kip1 expression is associated with ERG fusion-negative prostate cancer, but is unrelated to patient prognosis
2013 - Forschungsinformationssystem des UKE
Cysteine-rich secretory protein 3 overexpression is linked to a subset of PTEN-deleted ERG fusion-positive prostate cancers with early biochemical recurrence.
2013 - Forschungsinformationssystem des UKE
Reduced CD147 expression is linked to ERG fusion-positive prostate cancers but lacks substantial impact on PSA recurrence in patients treated by radical prostatectomy
2013 - Forschungsinformationssystem des UKE
Selective induction of apoptosis by HMG-CoA reductase inhibitors in hepatoma cells and dependence on p53 expression.
2012 - Forschungsinformationssystem des UKE
The promoter of human telomerase reverse transcriptase is activated during liver regeneration and hepatocyte proliferation.
2011 - Forschungsinformationssystem des UKE
Inhibition of experimental HCC growth in mice by use of the kinase inhibitor DMAT.
2011 - Forschungsinformationssystem des UKE
TMPRSS2-ERG -specific transcriptional modulation is associated with prostate cancer biomarkers and TGF-β signaling.
2011 - Forschungsinformationssystem des UKE - frei zugänglich

Aktive Facetten

Facetten

Zugriff

Einrichtung

Medientyp

Karte

Erscheinungsjahr

Autor/in

Sprache

Loss of CHD1 causes DNA repair defects and enhances prostate cancer therapeutic responsiveness

Prevalence of chromosomal rearrangements involving non-ETS genes in prostate cancer

High nuclear karyopherin α 2 expression is a strong and independent predictor of biochemical recurrence in prostate cancer patients treated by radical prostatectomy

High RNA-binding motif protein 3 expression is an independent prognostic marker in operated prostate cancer and tightly linked to ERG activation and PTEN deletions

Matrix Conditions and KLF2-Dependent Induction of Heme Oxygenase-1 Modulate Inhibition of HCV Replication by Fluvastatin

High c-MET expression is frequent but not associated with early PSA recurrence in prostate cancer.

SPINK1 expression is tightly linked to 6q15- and 5q21-deleted ERG-fusion negative prostate cancers but unrelated to PSA recurrence

Genomic deletion of MAP3K7 at 6q12-22 is associated with early PSA recurrence in prostate cancer and absence of TMPRSS2:ERG fusions

Intratumoral heterogeneity of KRAS mutation is rare in non-small-cell lung cancer.

Strong expression of the neuronal transcription factor FOXP2 is linked to an increased risk of early PSA recurrence in ERG fusion-negative cancers.

Loss of pSer2448-mTOR expression is linked to adverse prognosis and tumor progression in ERG-fusion-positive cancers.

High lysophosphatidylcholine acyltransferase 1 expression independently predicts high risk for biochemical recurrence in prostate cancers

Overexpression of the chromatin remodeler death-domain-associated protein in prostate cancer is an independent predictor of early prostate-specific antigen recurrence

Loss of CDKN1B/p27Kip1 expression is associated with ERG fusion-negative prostate cancer, but is unrelated to patient prognosis

Cysteine-rich secretory protein 3 overexpression is linked to a subset of PTEN-deleted ERG fusion-positive prostate cancers with early biochemical recurrence.

Reduced CD147 expression is linked to ERG fusion-positive prostate cancers but lacks substantial impact on PSA recurrence in patients treated by radical prostatectomy

Selective induction of apoptosis by HMG-CoA reductase inhibitors in hepatoma cells and dependence on p53 expression.

The promoter of human telomerase reverse transcriptase is activated during liver regeneration and hepatocyte proliferation.

Inhibition of experimental HCC growth in mice by use of the kinase inhibitor DMAT.

TMPRSS2-ERG -specific transcriptional modulation is associated with prostate cancer biomarkers and TGF-β signaling.